Full name
BIOSENS LABS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Scientific research and development activities
26.40.Z - Manufacture of electronic consumer products
46.90.Z - Non-specialized wholesale trade
62.01.Z - Activities related to programming, IT consulting, and related activities
70.22.Z - Head office activities and management consultancy
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
96.09.Z - Individual service activities
2021 | 2022 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | -0,9 | -1,1 | -27,7 |
EBITDA | -0,8 | -1 | -21,2 |
Short time liabilities | 1,4 | 2,2 | 57,1 |
Equity capital | 0,1 | -1 | -1684,6 |
Operating profit (EBIT) | -0,9 | -1 | -21,4 |
Assets | 1,5 | 1,8 | 16,6 |
Net profit (loss) | -0,9 | -1,1 | -27,7 |
Cash | 0,1 | 0,1 | -4,5 |
Liabilities and provisions for liabilities | 1,5 | 2,8 | 92,2 |
Net income from sale | 0 | 0,2 | 1497,4 |
Working assets | 0,8 | 0,7 | -10 |
Depreciation | 0,1 | 0,1 | 24,3 |
% | % | p.p. | |
Profitability of capital | -1318,9 | 106,3 | 1425,2 |
Equity capital to total assets | 4,3 | -57,8 | -62,1 |
Gross profit margin | -7398,3 | -591,6 | 6806,7 |
EBITDA Margin | -6795,7 | -515,7 | 6280 |
Days | Days | Days | |
Short term commitment turnover cycle | 43 217 | 4252 | -38 965 |
Current financial liquidity indicator | 0.555787980556488 | 0.2603234648704529 | -0,3 |
Net dept to EBITDA | -1.2848565578460693 | -2.0542309284210205 | -0,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane